Bruce Perkins MD MPH FRCPC is Professor, Endocrinologist, Epidemiologist and Clinician-Scientist in the Faculty of Medicine and the Institute for Health Policy Management and Evaluation at the University of Toronto. He holds the Sam and Judy Pencer Family Chair in Diabetes Clinical Research and directs the Leadership Sinai Centre for Diabetes. His research platform, research leadership, clinical practice, and advocacy work has focused entirely on strategies to improve the lives of those, like himself, living with type 1 diabetes. Using cohort and trial methods, his research has focused on 1) Early biomarkers and mechanisms of diabetes complications including neuropathy, and 2) complications prevention through artificial pancreas technologies, add-on-to-insulin drug therapies, and, more recently, immunomodulation and cell-based curative therapies. Among leadership in other projects funded by the Canadian Institutes for Health Research, National Institutes of Health, and JDRF, he sits on the Executive of the historic but ongoing “DCCT/EDIC” Study, and co-leads the Innovations in Type 1 Diabetes Goal Group within Diabetes Action Canada, a national patient-oriented research strategy. He has been awarded the Canadian Diabetes Association/CIHR Young Scientist Award, and the Gerald Wong Service Award from Diabetes Canada, for his research and advocacy.​